General Information of the Compound
Compound ID |
CP0316727
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
N-(2-phenylethyl)quinoxaline-2-carboxamide
Show/Hide
|
||||||||||||||||||
Synonyms |
2-quinoxalinecarboxamide, N-(2-phenylethyl)-
AC1NRYO0
AKOS001338925
BDBM50197271
CHEMBL245820
HMS2868E05
KB-55566
MCULE-6665471272
MLS001198127
MolPort-002-738-788
N-(2-phenylethyl)-2-quinoxalinecarboxamide
N-(2-phenylethyl)quinoxalin-2-ylcarboxamide
N-(2-phenylethyl)quinoxaline-2-carboxamide
N-phenethylquinoxaline-2-carboxamide
N~2~-phenethyl-2-quinoxalinecarboxamide
SCHEMBL7453913
SMR000559426
ST4122831
STK783123
VCRCXANKNYQHIW-UHFFFAOYSA-N
ZINC4744930
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C17H15N3O
|
||||||||||||||||||
Molecular Weight |
277.327
|
||||||||||||||||||
Canonical SMILES |
O=C(NCCc1ccccc1)c1cnc2ccccc2n1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C17H15N3O/c21-17(18-11-10-13-6-2-1-3-7-13)16-12-19-14-8-4-5-9-15(14)20-16/h1-9,12H,10-11H2,(H,18,21)
Show/Hide
|
||||||||||||||||||
InChIKey |
VCRCXANKNYQHIW-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound